Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001199835-24-000544
Filing Date
2024-12-12
Accepted
2024-12-12 12:42:15
Documents
36
Period of Report
2024-01-31

Document Format Files

Seq Description Document Type Size
1 POINT OF CARE NANO-TECHNOLOGY, INC. 10-Q pcnt-10q.htm   iXBRL 10-Q 422657
2 CERTIFICATIONS OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL AND ACCOUN pcnt-ex31.htm EX-31.1 15283
3 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL AND ACCOUNT pcnt-ex32.htm EX-32.1 5733
  Complete submission text file 0001199835-24-000544.txt   1741484

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE pcnt-20240131.xsd EX-101.SCH 15684
5 XBRL CALCULATION FILE pcnt-20240131_cal.xml EX-101.CAL 17117
6 XBRL DEFINITION FILE pcnt-20240131_def.xml EX-101.DEF 23409
7 XBRL LABEL FILE pcnt-20240131_lab.xml EX-101.LAB 109102
8 XBRL PRESENTATION FILE pcnt-20240131_pre.xml EX-101.PRE 84150
39 EXTRACTED XBRL INSTANCE DOCUMENT pcnt-10q_htm.xml XML 191615
Mailing Address 531 US HWY 22 EAST SUITE 232 WHITEHOUSE STATION NJ 08889
Business Address 531 US HWY 22 EAST SUITE 232 WHITEHOUSE STATION NJ 08889 732-723-7395
Point of Care Nano-Technology, Inc. (Filer) CIK: 0001504239 (see all company filings)

EIN.: 272830681 | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 000-56356 | Film No.: 241543997
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)